Dr. Frankel gets his license back
By Fred Gardner | Published in CounterPunch
On July 25, 2011, after an imposed hiatus of 15 months, Allan Frankel, MD, resumed seeing patients and authorizing Cannabis use.
The Medical Board of California had suspended Frankel’s license for reasons unrelated to Cannabis —and then sought to revoke it permanently because he used Cannabis himself.
You might say, “All’s well that ends well.” On the other hand, “Lost time is not found again.”
A Conventional Career
Frankel is 60, barrel-chested, curly-haired, and jolly —amazingly so, given that his parents were Holocaust survivors. He was a star fullback in high school and there’s something fullback-like about the way he drives straight ahead in pursuit of his interests. He is divorced, with three grown children —two who are practicing MDs and one with a business degree.
Most of Frankel’s career was spent practicing internal medicine. “I had a hotsy-totsy office on Wilshire Boulevard in Santa Monica,” he says, and an affiliation with UCLA. In 34 years of practice Frankel never had a problem with the medical board. He used marijuana on rare social occasions, and knew nothing about its medical aspect. For AIDS and cancer patients who said they’d been using marijuana beneficially, he issued letters of approval.
In 2001 Frankel underwent disk surgery for intractable back pain. In 2002 a viral infection of the heart almost killed him (he was given a prognosis of one year to live) and left him “in general, permanent discomfort.”
Frankel was disabled —bedridden for most of the ensuing three years. Relief came when some of the patients for whom he had written recommendations urged him to try cannabis.
“My patients did a reverse intervention on me,” Frankel says. “Cannabis helped me get better. A part of me thinks it saved my life.”
During his prolonged recovery, Frankel designed software that is still used to run the Bowyer Cancer Center at UCLA Hospital. He describes it as “a specialized medical language that enables them to build very complex what-if scenarios involving drug interactions, allergies, insurance, all the factors that have to be taken into account in a treatment plan.”
In March, 2006, Frankel opened a new office in Marina Del Rey dedicated to cannabis consultations. “I really didn’t know anything about cannabis except what I learned from my patients,” he reflects.
He joined the Society of Cannabis Clinicians that spring. (The first meeting he attended was the last chaired by founder Tod Mikuriya). He read the relevant medical and scientific literature, attended conferences, and did everything he could to educate himself about the body’s cannabinoid signaling system. He began tracking strain differences and encouraged patients to find the type of cannabis and the delivery system best suited to alleviating their symptoms. In other words, Allan Frankel was serious about mastering his new specialty.
Frankel says, “It wasn’t long before I realized that my patients were lying about how much they used —as if they feared my disapproval. Finally, I would tell them, ‘I use an ounce a month, How much do you really use?’ And then they would level with me —about dosage, about everything.”
In June 2007 two agents from the medical board’s enforcement division “walked into the office and announced that I was under investigation,” says Frankel. “They showed their badges in front of all the patients —it was terrible.”
A vindictive ex had filed a complaint against him. In addition to several false charges, he says, was a true one. As he would eventually acknowledge when he agreed to accept probation from the medical board, he had prescribed Vicodin for himself —”less than one pill a day on average”— while recovering from back surgery.
Although the self-prescribing had occurred years before Frankel become a cannabis specialist, the terms of his probation included a newly devised punishment: for one year, “Respondent shall not issue an oral or written recommendation or approval to a patient or a patient’s primary caregiver for the possession or cultivation of marijuana for the personal medical purposes of the patient.”
The medical board had recently added this punishment to their disciplinary options. Colleagues in the SCC urged Frankel not to accept it as a condition of probation, but to insist on a hearing to defend his right to recommend cannabis.
Frankel says he accepted the restriction because he didn’t have money to fight it, having just put two kids through med school. And he felt truly foolish and embarrassed about his self-prescribing. Cannabis had politicized him and he had become self-critical, in retrospect. When he accepted the board’s “stipulated settlement” offer in 2009, it was partly by way of penance for actions he considered irresponsible.
As of April 22, 2010, Allan Frankel, MD, stopped issuing approvals for patients to use cannabis. Other terms of his probation, which he complied with expeditiously, included
• taking courses in “prescribing practices,” “medical record keeping,” “ethics,” and “professional boundaries;”
• seeing a psychotherapist on a regular basis;
• undergoing a psychiatric evaluation by a psychiatrist chosen by the board;
• abstaining totally from alcohol (which had never been a problem for him); and
• submitting to random “biological fluid testing.”
Note that the disciplinary order Frankel agreed to abide by did not specifically rule out his using Cannabis as medicine (which the board knew he was doing).
The psychiatrist Frankel chose to see on a weekly basis was Robert Gerner, MD, of Los Angeles.
The psychiatrist the board chose to do a one-time evaluation was Daniel Fast, MD, of Beverly Hills. “I actually knew him slightly when I was at UCLA,” says Frankel of Fast. “Like, I’d nod to him in the cafeteria. He was usually sitting by himself. I wondered if he had any friends.”
Frankel made an appointment to see Fast on April 28, 2010, a few weeks into his forced lay-off. Based on their 63-minute conversation, Fast sent a report to the med board concluding that Frankel was unfit to practice medicine safely because of impaired cognitive function and “chronic marijuana usage.”
Dr. Fast Diagnoses Dr. Frankel
The following items are from Dr. Fast’s written evaluation of Dr. Frankel:
• “Dr. Frankel was born in New York City and moved to Redwood City, CA at age 7. He was captain of the football team and valedictorian in high school but never had sex. His father, who had lost a son in the concentrations camps, was never happy…”
• “Of these relationships, Dr. Frankel said ‘I’m attracted to borderline women’ and that it was ‘sloppy and wrong’ [to prescribe for his girlfriend and her daughter] but he was ‘in love’ and ‘will never do it again.’”
• “He has a good relationship with his sister, several old friends, his three adult children and a 16-month old grandson.”
• “He loves his work as CEO of Green Bridge Medical Services. 25% of his referrals are from doctors in the community. He loves to help patients, especially those with MS, HIV and cancer. He is active and excited about his new ventures —testing, developing tinctures [solutions of active cannabis] and medical education about cannabis. He currently acts as a ‘greeter’ in his business and has hired another physician to see patients.”
• “He reports that ‘life is good, even now.’ The worst is the ‘humiliation’ by the Medical Board which he believes is ‘political.’ He has no issue with the Medical Board restrictions, i.e. to prescribe no scheduled medication or to give marijuana recommendations… He accepts being unable to enjoy wine and won’t go back to doing what he was doing.”
• “Affective status: Mood is cheerful, optimistic and confident, inappropriate in this context.”
• There is no evidence of alterations of reality testing -no hallucinations, illusions or delusions. There is flight of ideas… There is preoccupation with the medical uses of marijuana.”
“I believe that Dr. Frankel suffers from a variety of psychiatric conditions which significantly interfere with his ability to process information, form judgments or relate a coherent history.”
Diagnosis based upon DSM-V Criteria:
• Axis I
• 304.30 Cannabis Dependence
• 305.20 Cannabis Abuse
• 292.89 Cannabis Intoxication
• Rule out underlying 296.89 Bipolar II Disorder or 301.13 Cyclothymic Disorder, Hypomanic.
• Rule out 314.9 Attention-Deficit/Hyperactivity Disorder Not Otherwise Specified.
• 301.9 Personality Disorder Not Otherwise Specified with Antisocial, Histrionic and Narcissistic features.
Following the psych eval by Fast, the med board notified Frankel that his license would be permanently revoked, pending a hearing at which he could defend himself.
The probation requirement that Frankel has allegedly violated reads, “Respondent shall abstain completely from the personal use or possession of controlled substances… and any drugs requiring a prescription. This prohibition does not apply to medications lawfully prescribed to Respondent by another practitioner for a bona fide illness or condition.”
Frankel was using cannabis with the approval of Christine Paoletti, MD. He was also using Cymbalta and Dalmane prescribed by Dr. Gerner for anxiety and insomnia. Frankel says he was first prescribed Dalmane when he was in his twenties, to quell “recurrent nightmares I’d been having since I was a kid in which the Nazis were coming to get me.”
Frankel’s lawyer, John Fleer, who has been handling cases before the med board for more than 20 years, said he had rarely seen an accusation as “desperately flawed” as the one pressed against Frankel. “The board is ignoring its own prior ‘Decision and Order’ by overruling Dr. Frankel’s personal physicians,” Fleer noted.
Beverly Hills Shrink
The hearing to determine whether Allan Frankel was fit to practice medicine was held in Los Angeles, December 27-30, 2010, before Administrative Law Judge Susan Formaker. The prosecution was handled by Deputy Attorney General Edward Kim, whose case rested on Daniel Fast’s expertise.
Fast, a small man in his 50s, has an orthodox resume and is a member of several psychiatric associations. He participated in “National Depression Screen Day,” an Eli Lilly scam intended to boost the number of Americans getting Prozac prescriptions.
On direct examination, Fast testified that he had done eight previous psych evals for the med board. He said he always asks doctors to come 15 minutes early to fill out paperwork, and that most arrive 15 minutes earlier than requested; but Allan Frankel, had arrived at his office seven minutes late! And he was not wearing a coat and tie, he was wearing slacks and a sports shirt!
[Rosie asks, “Who wears a coat and tie in LA?” And, “Those doctors who came a half hour early —how guilty were their consciences?”]
Frankel, according to Fast, had been cavalier about the medical board’s charges against him. He believed the prosecution to be “a witch hunt” that was “politically motivated.”
Yes, Frankel was contrite about the self-prescribing episode and some bad choices he’d made involving women, but not sufficiently contrite. In other words, Frankel, even facing loss of his license, remained his brash and breezy self.
Fast, the expert, testified that he himself had never approved marijuana use for depression, anxiety, or insomnia, preferring to prescribe pharmaceutical-industry synthetics. The psychoactive effects of marijuana, he stated on the stand, last for 14 days. A supporter of Frankel’s in the audience whispered, “Where can we get some of that stuff?”
A Fast and Complete Retreat
On cross-examination Fast would retract all the cannabis-related diagnoses he had made!
John Fleer began by calling Fast’s attention to the fact that the Diagnostic and Statistical Manual (the DSM, the so-called “Bible of the American Psychiatric Association”) requires doctors to choose two of the three conditions that he had pinned on Frankel.
Fast said, “Oh, you’re right. Well, I’ll choose ‘Dependence’ and ‘Abuse.’”
Fleer then had Fast read aloud from the DSM all the symptoms and traits that characterize “Cannabis Dependence” and “Cannabis Abuse,” and got him to admit that Frankel did not manifest any of them! According to Tyler Strause, “Fast was kind of puny to begin with and he seemed to be withering away on the stand. He wound up saying, ‘I was incorrect. I’m sorry.’”
Fleer matter-of-factly termed Fast’s inaccurate diagnoses “irresponsible” and moved on to the “Not Otherwise Specified” personality disorder. Fast testified that he had based his assessment on traits he observed in Frankel such as “impaired judgment,” “flight of ideas,” “poor impulse control,” and “lack of concentration.”
Fast had been consulting some notes while testifying. Fleer asked about them. Fast said they were notes he had made during his 63 minutes with Frankel. Fleer asked for and got copies. (No notes had been provided to the defense on “discovery,” the legally required pre-trial sharing of potential evidence.) Fleer then led Fast through a review of the notes, which revealed that Frankel had proceeded from topic to topic in a totally logical order.
How often, Fleer asked, did people in the general population exhibit aspects of an unspeficied personality disorder? This brought the stunning concession that Allan Frankel did not exhibit more signs of an unspecified personality disorder than most people Daniel Fast had encountered in his lifetime! “I couldn’t believe what I was hearing,” says Fleer. “It was unusual, to say the least.”
In Defense of Frankel
The doctor who approved Allan Frankel’s cannabis use, Christine Paoletti, MD, is a Santa Monica obstetrician whose practice has expanded to include cannabis consultations. Her testimony was “considered and deliberate,” according to Fleer. She had recommended that Frankel seek out and use CBD-rich cannabis, which is reported to be more effective against anxiety than high-THC strains. The judge picked up on this and Dr. Paoletti got to explain how cannabidiol had been bred out of Cannabis grown for maximum psychoactivity, but that CBD-rich strains were now becoming available for medical users.
According to Paoletti, the judge took over her cross-examination from Deputy AG Kim because “he wasn’t cutting to the chase and she got frustrated. She knew very little but asked good questions. She asked why I hadn’t asked for a note from his psychiatrist [confirming his diagnosis]. I had asked, but he hadn’t brought it. But he did have his primary care records documenting Insomnia and Anxiety. And that was substantial enough to justify the recommendation.”
Paoletti also noted that she had attended meetings of the Society of Cannabis Clinicians at which Frankel took an active part “and was always very cogent.”
Paoletti was asked by Formaker whether she had questioned Frankel about his past drug dependence. She said, “’No, he volunteered his history. I asked him to elaborate on certain aspects of it. When he was recovering from his cardiomyopathy he became concerned about addiction to Vicodan and went through a program.”
Paoletti considers Frankel’s use of cannabis as an alternative to Vicodin “a classic example of harm reduction.” She said, “I have several patients who have been able to get off their pain medications thanks to Cannabis.”
Formaker asked Paoletti if she had drug-tested Frankel. She said no, but she knew that he was being drug-tested as a condition of his probation. “My job,” she informed the judge, “was to determine ‘Did he have a medical condition that merits the use of cannabis?’ And ‘Is he stable?’
“‘Yes’ and ‘yes.’”
Two other MDs testified that Frankel was fit to practice medicine: Robert Gerner, the psychiatrist who was seeing Frankel on a weekly basis (as per the terms of his probation), and Glenn Gorletski, an internal medicine specialist who praised Frankel’s character and skills as a physician.
Gerner said that Frankel was coping very well while on probation. “His treatment regimen is working,” he said. “My advice is: ‘don’t change anything.’”
Frankel himself took the stand to state that he was aware of his prior transgressions, and remorseful. His goal was simply to show the judge that he could think and speak coherently. He did not expound on medical cannabis. Fleer was concerned that his expertise could be mistaken for a preoccupation.
Kim’s cross-examination was “lame,” according to Tyler Strause. “I was amazed how much of his time Kim devoted to flipping through his notes and papers trying to find some point with which he could contradict Dr. Frankel. He would flip through his papers for 30 seconds, then ask a three-second question. Over and over.”
Kim’s closing argument, says Fleer, revealed an assumption that Frankel had been “high” when he went for his appointment with Fast and will be “high” when treating patients, if allowed to practice again. Kim repeatedly reprised Fast’s complaint that Frankel had been seven minutes late and casually dressed.
“Kim got very worked up,” says Fleer, “trying to say that if you don’t wear a coat and tie, it means you’re high.” (Move over, Johnnie Cochran.)
“He really couldn’t accept the idea that Dr. Frankel could use marijuana and see patients. He had to be ‘high’ and therefore dysfunctional.”
In both his written report to the medical board and his direct testimony before ALJ Formaker, Daniel Fast had lingered on the transgressions involving women and prescription drugs that got Allan Frankel in trouble initially. But Frankel hadn’t skirted any med board guidelines since launching his cannabis-oriented practice in 2006, and he wasn’t accused of doing so. Fast thought Frankel showed insufficient remorse over things that happened before he became a medical cannabis user and proponent.
Administrative Law Judge Susan Formaker issued her 42-page proposed decision “In the Matter of the Accusation and Petition to Revoke Probation Against Allan I. Frankel, MD” in early March.
Daniel Fast’s testimony had been “substantially discredited on cross-examination,” she advised the medical board.
“In view of Dr. Fast’s problematic perceptions,” wrote Formaker, “Dr. Fast’s admittedly ‘inaccurate’ cannabis-related diagnoses and GAF scores assigned to Respondent, and the insufficiently supported diagnosis of Personality Disorder Not Otherwise Specified, Dr. Fast’s conclusions regarding respondent’s inability to practice medicine safely cannot be considered convincing.”
Formaker went on to weigh “the question of whether a physician may violate a probationary order issued by the Board solely through the use of medical marijuana authorized pursuant to the Compassionate Use Act.” Her answer was yes, “technically.”
But in this case, she noted, when Frankel and the Board entered into a stipulated settlement in March 2010, he agreed to abide by a disciplinary order that did not specifically rule out his using medical cannabis (which the board knew he was using).
Formaker opined: “Fundamental principles of due process require… before the Petition to Revoke Probation was filed, Respondent should have been notified… that his use of medical cannabis, in and of itself, constituted a violation… of the Disciplinary Order.”
This is hardly good news for pro-cannabis MDs (and others). All it means is that in the future, when certain doctors get offered a probation deal, the board will remind them that they are relinquishing the right to use cannabis as medicine under California law.
John Fleer commented: “The decision does give guidance to how this judge thinks the medical board could better prohibit medical cannabis use by a physician on probation. But I think one could successfully challenge such an attempt as improperly interfering with medical decision-making of the recommending physician.”
Frankel said about Formaker’s decision: “Even if nothing else good comes from my victory, it forces the medical board to come out and clearly state to any future docs that giving up cannabis will be part of their settlement; they won’t be able to set the doctors up. Had the Medical Board in fact told me that this were to be a restriction, I would have never settled… Also, the ‘negative’ is of great value in my opinion. Had I lost, things would be worse for everyone.”
One More Hoop to Jump Through
When the administrative law judge ruled in his favor, Frankel expected to resume practicing medicine on April 23, 2011 —a year and a day after he had been forced to stop. Some patients who were due for their annual renewal check-ups made appointments to see him that day.
But the board soon notified him that before he could see patients, he would have to be cleared by yet another psychiatrist. Given Fast’s ineptitude, the board reasoned, Frankel had not yet undergone a proper psych eval.
“Dr. Frankel will not comply,” Fleer wrote the board April 29, adding that he would file a writ in Superior Court to impel them to let Frankel resume practicing medicine without further delay and without any “marijuana restriction.”
Fleer also notified Fast that Frankel would file a malpractice suit against him in 90 days.
“By not understanding the diagnoses he was making,” Fleer says, “Dr. Fast failed to meet the appropriate standard of care. As a result, Dr. Frankel couldn’t practice and lost income. He had to pay the cost of defending himself. And he was put through considerable emotional stress.”
Frankel wonders if the medical board somehow signaled Fast that they wanted him to produce a negative evaluation. Fleer doubts they would be that crass; but, he says, “This lawsuit is going to have discovery and I’m going to pursue all the comunications that Dr. Fast had with the board.”
Frankel doesn’t know if the legal action against their discredited expert caused a change in attitude, but at a July 12 meeting with his probation officer and a supervisor from the enforcement division, he says he was “treated respectfully for the first time ever.”
Frankel consented to yet another psych eval, but fearing a repeat encounter with an “expert” who knew nothing about cannabis, he requested the right to record his interchange with the board’s new psychiatrist of choice, Nathan Lavid.
He was assured that he could tape the session and, assuming he passed, would be allowed to see patients and issue cannabis recommendations. Something said by the supervisor left Frankel with the impression that the board did not intend to use Fast as an expert in the future.
On July 15, Frankel went to see Dr. Lavid. He arrived on time, but did not wear a suit and tie.
Ten days later he received an email from his probation officer, Kevin Morris: “I am happy to inform you that you passed the psychiatric evaluation and can resume the practice of medicine immediately. Please see the formal letter attached, which you will be receiving in the mail shortly. Have a good day.”
Frankel did indeed resume seeing patients immediately, and had a good day. He is sharing office space with Dr. Paoletti in Santa Monica, and can be reached at email@example.com.
Sam Sabzehzar is one of the Co-founders of Medical Marijuana 411. With a foundation of investigative and transactional research on botanicals delivered to the body’s endocannabinoid system, Mr. Sabzehzar has developed unparalleled expertise in the cannabis industry. Throughout, he has established rich relationships with diverse individuals and organizations including nonprofits focused on advocacy, public policy, and science.